Results 111 to 120 of about 135,678 (188)

Activation of the alternative complement pathway and its relevance for sodium retention in experimental nephrotic syndrome. [PDF]

Pflugers Arch
Essigke D, Kalo MZ, Kong L, Wörn M, Saad MK, Omage K, Bohnert BN, Birkenfeld AL, Atkinson JP, Wu X, Artunc F.   +10 more
europepmc   +1 more source

Reply to Letter: "Limitations of Complement Activity Assays as Biomarkers for Ravulizumab Therapeutic Monitoring" by Saccà and Pelto Regarding "Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab". [PDF]

Ann Clin Transl Neurol
Gerischer L, Schroeder-Braunstein J, Wabnitz G, Meisel A.   +3 more
europepmc   +1 more source

Genetic Variation in the Alternative Complement Pathway Contributes to Individual Susceptibility to Bacteremia and Sepsis. [PDF]

Crit Care Explor
Inman K, Chernus J, Lee M, Alder JK, Shah FA, Mayr FB, Dempsey T, Nouraie SM, Dela Cruz C, Ferreira VP, Kulkarni HS, Meyer NJ, Strollo PJ, Feingold E, Bain W.   +14 more
europepmc   +1 more source

Alternative Complement Pathway Activation Provokes a Hypercoagulable State with Diminished Fibrinolysis. [PDF]

Shock, 2020
Samuels JM, Coleman JR, Moore EE, Bartley M, Vigneshwar N, Cohen M, Silliman CC, Sauaia A, Banerjee A.   +8 more
europepmc   +1 more source

Editorial: Community series in the role of complement in health and disease, volume II

Frontiers in Immunology
Maciej Cedzyński, Thomas Vorup-Jensen, Thomas Vorup-Jensen, Marcin Okrój, Anna S. Świerzko   +4 more
doaj   +1 more source

CR2-fH, A Targeted Inhibitor of Alternative Complement Pathway Reduces Dry AMD-Like Phenotype in AMD Patient iPSC-derived RPE Cells. [PDF]

Invest Ophthalmol Vis Sci
Navneet S, Rohrer B.
europepmc   +1 more source

Modeling the activation of the alternative complement pathway and its effects on hemolysis in health and disease. [PDF]

PLoS Comput Biol, 2020
Caruso A, Vollmer J, Machacek M, Kortvely E.   +3 more
europepmc   +1 more source

Thrombospondin-1 inhibits alternative complement pathway activation in antineutrophil cytoplasmic antibody-associated vasculitis. [PDF]

J Clin Invest
Konwar S, Schroda S, Rogg M, Kleindienst J, Decker EL, Pohl M, Zieger B, Panse J, Wang H, Grosse R, Schell C, Vidal S, Liu X, Gorzelanny C, Tschongov T, Häffner K.   +15 more
europepmc   +1 more source

Increased Alternative Complement Pathway Function and Improved Survival during Critical Illness. [PDF]

Am J Respir Crit Care Med, 2020
Bain W, Li H, van der Geest R, Moore SR, Olonisakin TF, Ahn B, Papke E, Moghbeli K, DeSensi R, Rapport S, Saul M, Hulver M, Xiong Z, Mallampalli RK, Ray P, Morris A, Ma L, Doi Y, Zhang Y, Kitsios GD, Kulkarni HS, McVerry BJ, Ferreira VP, Nouraie M, Lee JS.   +24 more
europepmc   +1 more source

The specific contributions of factor H and factor I in controlling fluid phase activation of the alternative complement pathway. [PDF]

Sci Rep
Turner NA, Moake JL.
europepmc   +1 more source